Use of neomycin for treating angiogenesis-related diseases
CA 2331620 A1 · Owner: Vallee, Bert L. · Inventors: Vallee, Bert L.; Hu, Guo-Fu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to using neomycin or an analogue thereof as a therapeutic agent to treat angiogenesis-related diseases which are , characterized by excessive undesired or inappropriate angiogenesis or proliferation of endothelial cells. The present invention is also directed to pharmaceutical compositions comprising: (a) neomycin or an analogue and optionally, (b) another anti-angiogenic agent or an anti-neoplastic agent. The present invention is further directed to a method for screening neomycin analogues having anti-angiogenic activity. A preferred embodiment of the invention relates to using neomycin to treat subjects having such diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 11, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 11, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 11, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.